Gert Gabriëls Department of Internal Medicine D, Experimental Nephrology University of Münster Biography Publications Institution JoVE Articles Gert Gabriëls has not added a biography. If you are Gert Gabriëls and would like to personalize this page please email our Author Liaison for assistance. Publications Preclinical Evaluation of Racotumomab, an Anti-idiotype Monoclonal Antibody to N-glycolyl-containing Gangliosides, with or Without Chemotherapy in a Mouse Model of Non-small Cell Lung Cancer Frontiers in Oncology. 2012 | Pubmed ID: 23162791 Racotumomab: an Anti-idiotype Vaccine Related to N-glycolyl-containing Gangliosides - Preclinical and Clinical Data Frontiers in Oncology. 2012 | Pubmed ID: 23110257 Antitumor Protection by NGcGM3/VSSP Vaccine Against Transfected B16 Mouse Melanoma Cells Overexpressing N-glycolylated Gangliosides In Vivo (Athens, Greece). Jul, 2012 | Pubmed ID: 22773575 Detection of N-glycolyl GM3 Ganglioside in Neuroectodermal Tumors by Immunohistochemistry: an Attractive Vaccine Target for Aggressive Pediatric Cancer Clinical & Developmental Immunology. 2011 | Pubmed ID: 21941577 Tissue Factor As a Novel Marker for Detection of Circulating Cancer Cells Biomarkers : Biochemical Indicators of Exposure, Response, and Susceptibility to Chemicals. Feb, 2011 | Pubmed ID: 21128872 Optimization of Molecular Detection of GD2 Synthase MRNA in Retinoblastoma Molecular Medicine Reports. Mar-Apr, 2010 | Pubmed ID: 21472230 NGcGM3 Ganglioside: a Privileged Target for Cancer Vaccines Clinical & Developmental Immunology. 2010 | Pubmed ID: 21048926 Direct Validation of NGcGM3 Ganglioside As a New Target for Cancer Immunotherapy Expert Opinion on Biological Therapy. Feb, 2010 | Pubmed ID: 20088712 Detection and Characterization of N-glycolyated Gangliosides in Wilms Tumor by Immunohistochemistry Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. Jan-Feb, 2010 | Pubmed ID: 19435393 Combined Therapeutic Effect of a Monoclonal Anti-idiotype Tumor Vaccine Against NeuGc-containing Gangliosides with Chemotherapy in a Breast Carcinoma Model Breast Cancer Research and Treatment. Apr, 2010 | Pubmed ID: 19377876 Exogenous Incorporation of Neugc-rich Mucin Augments N-glycolyl Sialic Acid Content and Promotes Malignant Phenotype in Mouse Tumor Cell Lines Journal of Experimental & Clinical Cancer Research : CR. 2009 | Pubmed ID: 19951433 [Molecular Detection of Minimal Residual Disease in Melanoma and Solid Tumors] Medicina. 2009 | Pubmed ID: 19414304 Molecular Detection of Circulating Tyrosinase MRNA: Optimization in a Preclinical Xenograft Mouse Melanoma Model and Further Evaluation in Samples from Advanced Melanoma Patients International Journal of Molecular Medicine. May, 2008 | Pubmed ID: 18425346 1E10 Anti-idiotype Vaccine in Non-small Cell Lung Cancer: Experience in Stage IIIb/IV Patients Cancer Biology & Therapy. Dec, 2007 | Pubmed ID: 18075301 Practical Guidelines for Diagnostic Use of in Vitro Chemosensitivity Tests Anticancer Research. May-Jun, 2007 | Pubmed ID: 17593632 Active Immunotherapy with 1E10 Anti-idiotype Vaccine in Patients with Small Cell Lung Cancer: Report of a Phase I Trial Cancer Biology & Therapy. Feb, 2007 | Pubmed ID: 17218777 Complete Antitumor Protection by Perioperative Immunization with GM3/VSSP Vaccine in a Preclinical Mouse Melanoma Model Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2006 | Pubmed ID: 17145833 Active Specific Immunotherapy of Melanoma with a GM3 Ganglioside-based Vaccine: a Report on Safety and Immunogenicity Journal of Immunotherapy (Hagerstown, Md. : 1997). Nov-Dec, 2004 | Pubmed ID: 15534488 Immunotherapy of Advanced Breast Cancer with a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Mar, 2003 | Pubmed ID: 12637465 Role of Cell Surface GM3 Ganglioside and Sialic Acid in the Antitumor Activity of a GM3-based Vaccine in the Murine B16 Melanoma Model Journal of Cancer Research and Clinical Oncology. Dec, 2002 | Pubmed ID: 12474053 הדמיה לא פולשנית של דחיית שתל חריפה לאחר השתלת כליה באמצעות חולדה Alexander Grabner*1, Dominik Kentrup*1, Uta Schnöckel2, Gert Gabriëls1, Rita Schröter1, Hermann Pavenstädt1, Otmar Schober2, Eberhard Schlatter1, Michael Schäfers*3, Stefan Reuter*1 1Department of Internal Medicine D, Experimental Nephrology, University of Münster, 2Department of Nuclear Medicine, University of Münster, 3European Institute for Molecular Imaging, University of Münster JoVE 4240 Medicine
הדמיה לא פולשנית של דחיית שתל חריפה לאחר השתלת כליה באמצעות חולדה Alexander Grabner*1, Dominik Kentrup*1, Uta Schnöckel2, Gert Gabriëls1, Rita Schröter1, Hermann Pavenstädt1, Otmar Schober2, Eberhard Schlatter1, Michael Schäfers*3, Stefan Reuter*1 1Department of Internal Medicine D, Experimental Nephrology, University of Münster, 2Department of Nuclear Medicine, University of Münster, 3European Institute for Molecular Imaging, University of Münster JoVE 4240 Medicine